David Joyner, a longtime CVS executive, speaks during a Senate Health, Education, Labor and Pensions Committee hearing in Washington, D.C., on May 10, 2023.CVS Health CEO David Joyner on Wednesday defended controversial pharmacy middlemen like his company's Caremark unit, which are widely accused of inflating prescription medication prices, and instead accused manufacturers of "monopolistic tendencies" that keep drug costs high in the U.S. Joyner, who stepped into the role in October, spent much of his open ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Shares of CVS Health (CVS 14.57%) were soaring Wednesday after the diversified healthcare giant's fourth-quarter results topped estimates and management offered better-than-expected guidance for 2025.As of 11:52 a.m. ET, the stock was up 14.5% on the news. CVS hops over a low barCVS, which operates the nation's largest pharmacy chain, health insurer Aetna, and the pharmacy benefit manager Caremark, beat estimates on the top and bottom lines in the fourth quarter. Revenue rose 4.2% to $97.7 billion, compared ...

CVS Health reported mixed fourth-quarter earnings, beating estimates but showing challenges in key areas.CVS Health (CVS 14.56%), a leading integrated healthcare and pharmacy solutions provider, released its fourth-quarter 2024 earnings on February 12, 2025. The earnings surpassed analyst expectations with an adjusted earnings per share (EPS) of $1.19, beating estimates of $0.91 by 30.8%. Total revenue reached $97.7 billion, exceeding the $97.1 billion forecast and marking a year-over-year increase of 4.2%. ...

CVS Health Corporation (NYSE:CVS) Q4 2024 Earnings Conference Call February 12, 2025 8:00 AM ET Company Participants David Joyner - President, Chief Executive Officer Tom Cowhey - Executive Vice President, Chief Financial Officer Prem Shah - Group President, CVS Health Steve Nelson - President, Aetna Larry McGrath - Chief Strategy Officer, Investor Relations Conference Call Participants Lisa Gill - JP Morgan Justin Lake - Wolfe Research Stephen Baxter - Wells Fargo Andrew Mok - Barclays Erin Wright - Morga ...

CVS Health Corporation (CVS) posted adjusted earnings per share (EPS) of $1.19 in the fourth quarter of 2024, down 43.9% year over year. However, the metric topped the Zacks Consensus Estimate by 33.7%. The adjusted EPS figure considers certain asset amortization costs, loss on assets held for sale and other adjustments.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.On a reported basis, the company’s GAAP earnings were $1.30 per share compared with $1.58 in the prior-year period.  Fo ...

CVS Health (CVS) came out with quarterly earnings of $1.19 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $2.12 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 33.71%. A quarter ago, it was expected that this drugstore chain and pharmacy benefits manager would post earnings of $1.07 per share when it actually produced earnings of $1.09, delivering a surprise of 1.87%.Over the l ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to_________ Commission file number: 001-01011 CVS HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 05-0494040 (State or ...

CVS Health on Wednesday reported fourth-quarter revenue and profit that topped estimates, even as its troubled insurance business continued to see higher medical costs. The company also issued a full-year 2025 adjusted earnings outlook of $5.75 to $6 per share, which was in line with Wall Street's expectations. But CVS did not provide a revenue forecast for the year. It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain. Joyner succeede ...

Exhibit 99.1 CVS HEALTH CORPORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2024 RESULTS Fourth Quarter Highlights Full-Year Highlights 2025 Full-Year Guidance CEO Commentary "Our integrated model allows us to uniquely deliver a simpler, connected experience that saves time, saves money, and improves health. We have continued to see growth in key areas of our business, including the Pharmacy and Consumer Wellness segment, while we address the industry-wide challenges that have impacted our Health Care Benefits ...